Clinical Trial Update: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of SJP-0132 Eye Drops in Chinese patients with dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• SJP-0132 Eye Drops

Snippet

Sponsor: Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd. | Conditions: Dry Eye | Phase 3 | Status: COMPLETED